FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:RBCK1-ANO9 (FusionGDB2 ID:72622)

Fusion Gene Summary for RBCK1-ANO9

check button Fusion gene summary
Fusion gene informationFusion gene name: RBCK1-ANO9
Fusion gene ID: 72622
HgeneTgene
Gene symbol

RBCK1

ANO9

Gene ID

10616

338440

Gene nameRANBP2-type and C3HC4-type zinc finger containing 1anoctamin 9
SynonymsC20orf18|HOIL-1|HOIL1|PBMEI|PGBM1|RBCK2|RNF54|UBCE7IP3|XAP3|XAP4|ZRANB4PIG5|TMEM16J|TP53I5
Cytomap

20p13

11p15.5

Type of geneprotein-codingprotein-coding
DescriptionranBP-type and C3HC4-type zinc finger-containing protein 1HBV-associated factor 4RBCC protein interacting with PKC1RING finger protein 54RING-type E3 ubiquitin transferase HOIL-1heme-oxidized IRP2 ubiquitin ligase 1hepatitis B virus X-associated proanoctamin-9p53-induced gene 5 proteintransmembrane protein 16Jtumor protein p53-inducible protein 5
Modification date2020032720200320
UniProtAcc.

A1A5B4

Ensembl transtripts involved in fusion geneENST00000382181, ENST00000353660, 
ENST00000356286, ENST00000400245, 
ENST00000400247, ENST00000475269, 
ENST00000332826, 
Fusion gene scores* DoF score9 X 5 X 6=2704 X 4 X 4=64
# samples 84
** MAII scorelog2(8/270*10)=-1.75488750216347
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(4/64*10)=-0.678071905112638
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: RBCK1 [Title/Abstract] AND ANO9 [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointRBCK1(400375)-ANO9(428826), # samples:1
Anticipated loss of major functional domain due to fusion event.RBCK1-ANO9 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
RBCK1-ANO9 seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneRBCK1

GO:0000209

protein polyubiquitination

12629548|17006537

HgeneRBCK1

GO:0032088

negative regulation of NF-kappaB transcription factor activity

17449468

HgeneRBCK1

GO:0043123

positive regulation of I-kappaB kinase/NF-kappaB signaling

19136968|21455173

HgeneRBCK1

GO:0050852

T cell receptor signaling pathway

20005846

HgeneRBCK1

GO:0051092

positive regulation of NF-kappaB transcription factor activity

19136968

HgeneRBCK1

GO:0097039

protein linear polyubiquitination

21455173|21455180|21455181|23453807

TgeneANO9

GO:1902939

negative regulation of intracellular calcium activated chloride channel activity

22946059


check buttonFusion gene breakpoints across RBCK1 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across ANO9 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4READTCGA-F5-6465-01ARBCK1chr20

400375

+ANO9chr11

428826

-


Top

Fusion Gene ORF analysis for RBCK1-ANO9

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
Frame-shiftENST00000382181ENST00000332826RBCK1chr20

400375

+ANO9chr11

428826

-
In-frameENST00000353660ENST00000332826RBCK1chr20

400375

+ANO9chr11

428826

-
In-frameENST00000356286ENST00000332826RBCK1chr20

400375

+ANO9chr11

428826

-
intron-3CDSENST00000400245ENST00000332826RBCK1chr20

400375

+ANO9chr11

428826

-
intron-3CDSENST00000400247ENST00000332826RBCK1chr20

400375

+ANO9chr11

428826

-
intron-3CDSENST00000475269ENST00000332826RBCK1chr20

400375

+ANO9chr11

428826

-

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000356286RBCK1chr20400375+ENST00000332826ANO9chr11428826-300314615762894772
ENST00000353660RBCK1chr20400375+ENST00000332826ANO9chr11428826-274011985682631687

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000356286ENST00000332826RBCK1chr20400375+ANO9chr11428826-0.0138993580.9861006
ENST00000353660ENST00000332826RBCK1chr20400375+ANO9chr11428826-0.0217927280.9782073

Top

Fusion Genomic Features for RBCK1-ANO9


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.
genomic feature

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for RBCK1-ANO9


check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr20:400375/chr11:428826)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
.ANO9

A1A5B4

FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}.FUNCTION: Has calcium-dependent phospholipid scramblase activity; scrambles phosphatidylserine, phosphatidylcholine and galactosylceramide (By similarity). Does not exhibit calcium-activated chloride channel (CaCC) activity (PubMed:22178883). Can inhibit the activity of ANO1 (PubMed:20056604, PubMed:22946059). {ECO:0000250|UniProtKB:P86044, ECO:0000269|PubMed:20056604, ECO:0000269|PubMed:22178883, ECO:0000269|PubMed:22946059}.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+51155_119210469.0DomainUbiquitin-like
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+61255_119252511.0DomainUbiquitin-like
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+612193_222252511.0Zinc fingerRanBP2-type
TgeneANO9chr20:400375chr11:428826ENST000003328261023353_373305783.0Topological domainExtracellular
TgeneANO9chr20:400375chr11:428826ENST000003328261023395_423305783.0Topological domainCytoplasmic
TgeneANO9chr20:400375chr11:428826ENST000003328261023445_552305783.0Topological domainExtracellular
TgeneANO9chr20:400375chr11:428826ENST000003328261023574_604305783.0Topological domainCytoplasmic
TgeneANO9chr20:400375chr11:428826ENST000003328261023626_703305783.0Topological domainExtracellular
TgeneANO9chr20:400375chr11:428826ENST000003328261023725_782305783.0Topological domainCytoplasmic
TgeneANO9chr20:400375chr11:428826ENST000003328261023332_352305783.0TransmembraneHelical
TgeneANO9chr20:400375chr11:428826ENST000003328261023374_394305783.0TransmembraneHelical
TgeneANO9chr20:400375chr11:428826ENST000003328261023424_444305783.0TransmembraneHelical
TgeneANO9chr20:400375chr11:428826ENST000003328261023553_573305783.0TransmembraneHelical
TgeneANO9chr20:400375chr11:428826ENST000003328261023605_625305783.0TransmembraneHelical
TgeneANO9chr20:400375chr11:428826ENST000003328261023704_724305783.0TransmembraneHelical

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+511233_261210469.0Coiled coilOntology_term=ECO:0000255
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+612233_261252511.0Coiled coilOntology_term=ECO:0000255
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+511278_506210469.0RegionTRIAD supradomain
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+612278_506252511.0RegionTRIAD supradomain
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+511193_222210469.0Zinc fingerRanBP2-type
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+511282_332210469.0Zinc fingerRING-type 1
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+511351_411210469.0Zinc fingerIBR-type
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+511447_476210469.0Zinc fingerRING-type 2%3B atypical
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+612282_332252511.0Zinc fingerRING-type 1
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+612351_411252511.0Zinc fingerIBR-type
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+612447_476252511.0Zinc fingerRING-type 2%3B atypical
TgeneANO9chr20:400375chr11:428826ENST0000033282610231_198305783.0Topological domainCytoplasmic
TgeneANO9chr20:400375chr11:428826ENST000003328261023220_264305783.0Topological domainExtracellular
TgeneANO9chr20:400375chr11:428826ENST000003328261023286_331305783.0Topological domainCytoplasmic
TgeneANO9chr20:400375chr11:428826ENST000003328261023199_219305783.0TransmembraneHelical
TgeneANO9chr20:400375chr11:428826ENST000003328261023265_285305783.0TransmembraneHelical


Top

Fusion Gene Sequence for RBCK1-ANO9


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.
>72622_72622_1_RBCK1-ANO9_RBCK1_chr20_400375_ENST00000353660_ANO9_chr11_428826_ENST00000332826_length(transcript)=2740nt_BP=1198nt
GCGCCGGGACCGCTGGGACCCCGCACTCGGCGTCCGCCGCCGCCGGGTAGCCGGGCAGTGGAGGTCCCGGATGAGGCGACAATTTTTCCG
GCCCCCCCTCCCAGTCCCGCCCCACTTCCGGGGCCGCCACTTTCACTTTCTCTTCCGCCGAAGCCGCTCCCCTTGCGAAGAACTGGGGCC
TCCCGGGAGGAGAGAGGGCTTTGCCTTGAAACCCGGGACGCCAGGGGCGCTCCCGCAAGTGGGGGTCCTCCGGGACTTGGAACGCCCCGG
CTGGGTGGTGTCCGGGCGTCCTTTCCCCGCTTCTTCCCACCTCGGCTGGTCCCGTTTCCTCCTGCGCCCAGTGCGGACCTGTCTCGGCGC
CCGCTGCCCTCTCACCGCCCCACGCAGGATCCCGGCCTGGTCACCGGGCAGTGTGATGCTTCCCGACTGCCGCGGGGACAGCGAGGCACA
CACAGGGCTTGGGCCGCGCCGGAGGCCACACGGCCTGGCTGAGTTGCTCCTGGTCTCCCGCCTCTCCCAGGCGACCCGGAGGTAGCATTT
CCCAGGAGGCACGGTCCCCCCCAGGGGGATGGGCACAGCCACGCCAGATGGACGAGAAGACCAAGAAAGGCTGTGGGTGAGCGTGGAGGA
TGCTCAGATGCACACCGTCACCATCTGGCTCACAGTGCGCCCTGATATGACAGTGGCGTCTCTCAAGGACATGGTTTTTCTGGACTATGG
CTTCCCACCAGTCTTGCAGCAGTGGGTGATTGGGCAGCGGCTGGCACGAGACCAGGAGACCCTGCACTCCCATGGGGTGCGGCAGAATGG
GGACAGTGCCTACCTCTATCTGCTGTCAGCCCGCAACACCTCCCTCAACCCTCAGGAGCTGCAGCGGGAGCGGCAGCTGCGGATGCTGGA
AGATCTGGGCTTCAAGGACCTCACGCTGCAGCCGCGGGGCCCTCTGGAGCCAGGCCCCCCAAAGCCCGGGGTCCCCCAGGAACCCGGACG
GGGGCAGCCAGATGCAGTGCCTGAGCCCCCACCGGTGGGCTGGCAGTGCCCCGGGTGCACCTTCATCAACAAGCCCACGCGGCCTGGCTG
TGAGATGTGCTGCCGGGCGCGCCCCGAGGCCTACCAGGTCCCCGCCTCATACCAGCCCGACGAGGAGGAGCGAGCGCGCCTGGCGGGCGA
GGAGGAGGCGCTGCGTCAGTACCAGCAGGAGGAAATGGCACTTCAGCTCATTAACTGCCCCGACTACAAGCTCCGGCCATACCAGCACTC
CTACCTACGCAGCACCGTCATCCTCGTCCTGACCCTGCTCATGATCTGCCTCATGATCGGCATGGCCCACGTCCTGGTGGTCTACCGCGT
CCTGGCCTCCGCGCTCTTCAGCAGCTCGGCCGTGCCCTTCCTGGAGGAGCAGGTGACCACGGCCGTGGTGGTGACCGGGGCTCTGGTGCA
CTATGTGACCATCATCATCATGACCAAGATCAACAGGTGCGTGGCCCTGAAGCTTTGTGACTTCGAGATGCCCAGGACCTTCTCGGAGCG
AGAGAGCAGGTTCACCATCCGCTTCTTCACACTGCAGTTCTTCACCCATTTCTCGTCTCTCATCTACATCGCCTTCATCCTGGGCAGGAT
CAACGGCCACCCCGGGAAGTCCACGCGCCTGGCGGGCTTGTGGAAGCTGGAAGAGTGCCACGCCAGCGGCTGCATGATGGACCTCTTCGT
GCAGATGGCCATCATCATGGGCCTGAAGCAGACGCTCAGCAACTGCGTCGAGTACCTGGTCCCGTGGGTGACCCACAAGTGCCGCTCTCT
GCGGGCCTCCGAGTCCGGGCACCTGCCCCGGGACCCCGAGCTCAGGGACTGGCGGCGCAACTACCTTCTGAACCCGGTCAACACCTTCAG
CCTGTTCGACGAGTTCATGGAGATGATGATCCAGTACGGCTTCACCACCATCTTCGTGGCCGCCTTCCCGCTGGCGCCGCTGCTCGCGCT
CTTCAGCAACCTCGTGGAGATCCGCCTGGACGCCATCAAGATGGTCTGGTTGCAGCGGCGCCTGGTGCCGCGCAAGGCCAAGGACATCGG
GACCTGGCTGCAGGTGCTGGAGACCATCGGTGTGCTGGCGGTCATTGCCAATGGGATGGTCATTGCCTTCACATCTGAGTTCATCCCCCG
AGTGGTCTACAAGTACCGCTATAGCCCATGCCTGAAAGAAGGCAACTCTACTGTCGACTGCCTCAAGGGCTACGTCAACCACAGCCTGTC
CGTCTTCCACACCAAGGACTTCCAGGACCCTGATGGGATTGAGGGCTCAGAAAACGTGACTCTGTGCAGATACAGGGACTACCGCAATCC
CCCCGATTACAACTTCTCCGAGCAGTTCTGGTTCCTCCTGGCCATCCGCCTGGCCTTCGTCATCCTCTTTGAGCACGTGGCCTTGTGCAT
CAAGCTCATCGCCGCCTGGTTCGTGCCCGACATCCCTCAGTCGGTGAAGAACAAGGTTCTGGAGGTGAAGTACCAGAGGCTGCGTGAGAA
GATGTGGCATGGAAGGCAGAGGCTGGGTGGGGTGGGGGCAGGCTCTCGGCCCCCAATGCCTGCCCATCCCACCCCAGCATCCATCTTCAG
TGCCAGGAGCACAGACGTGTAGGGCCAGAGCCCGTCCAGAGGCCACCAGGAGCTGAGACAGTGCCACCACCAGCACCTCCCACAAGCCCA

>72622_72622_1_RBCK1-ANO9_RBCK1_chr20_400375_ENST00000353660_ANO9_chr11_428826_ENST00000332826_length(amino acids)=687AA_BP=209
MGTATPDGREDQERLWVSVEDAQMHTVTIWLTVRPDMTVASLKDMVFLDYGFPPVLQQWVIGQRLARDQETLHSHGVRQNGDSAYLYLLS
ARNTSLNPQELQRERQLRMLEDLGFKDLTLQPRGPLEPGPPKPGVPQEPGRGQPDAVPEPPPVGWQCPGCTFINKPTRPGCEMCCRARPE
AYQVPASYQPDEEERARLAGEEEALRQYQQEEMALQLINCPDYKLRPYQHSYLRSTVILVLTLLMICLMIGMAHVLVVYRVLASALFSSS
AVPFLEEQVTTAVVVTGALVHYVTIIIMTKINRCVALKLCDFEMPRTFSERESRFTIRFFTLQFFTHFSSLIYIAFILGRINGHPGKSTR
LAGLWKLEECHASGCMMDLFVQMAIIMGLKQTLSNCVEYLVPWVTHKCRSLRASESGHLPRDPELRDWRRNYLLNPVNTFSLFDEFMEMM
IQYGFTTIFVAAFPLAPLLALFSNLVEIRLDAIKMVWLQRRLVPRKAKDIGTWLQVLETIGVLAVIANGMVIAFTSEFIPRVVYKYRYSP
CLKEGNSTVDCLKGYVNHSLSVFHTKDFQDPDGIEGSENVTLCRYRDYRNPPDYNFSEQFWFLLAIRLAFVILFEHVALCIKLIAAWFVP

--------------------------------------------------------------
>72622_72622_2_RBCK1-ANO9_RBCK1_chr20_400375_ENST00000356286_ANO9_chr11_428826_ENST00000332826_length(transcript)=3003nt_BP=1461nt
CGCCTGCGGCCCAGCTCCTTCCCGCGGCTCTGCGATGCGGCCCGCAGGGTGACCCGGGCGGGAGTCCGGGGACCCGCGATCAGCCCCGGA
GGACGGGGTGGGGTCGCCCCAAACAGGAGCGCCGGGACCGCTGGGACCCCGCACTCGGCGTCCGCCGCCGCCGGGTAGCCGGGCAGTGGA
GGTCCCGGATGAGGCGACAATTTTTCCGGCCCCCCCTCCCAGTCCCGCCCCACTTCCGGGGCCGCCACTTTCACTTTCTCTTCCGCCGAA
GCCGCTCCCCTTGCGAAGAACTGGGGCCTCCCGGGAGGAGAGAGGGCTTTGCCTTGAAACCCGGGACGCCAGGGGCGCTCCCGCAAGTGG
GGGTCCTCCGGGACTTGGAACGCCCCGGCTGGGTGGTGTCCGGGCGTCCTTTCCCCGCTTCTTCCCACCTCGGCTGGTCCCGTTTCCTCC
TGCGCCCAGTGCGGACCTGTCTCGGCGCCCGCTGCCCTCTCACCGCCCCACGCAGGATCCCGGCCTGGTCACCGGGCAGTGTGATGCTTC
CCGACTGCCGCGGGGACAGCGAGGCACACACAGGGCTTGGGCCGCGCCGGAGGCCACACGGCCTGGCTGAGTTGCTCCTGGTCTCCCGCC
TCTCCCAGGCGACCCGGAGGTAGCATTTCCCAGGAGGCACGGTCCCCCCCAGGGGGATGGGCACAGCCACGCCAGATGGACGAGAAGACC
AAGAAAGCAGAGGAAATGGCCCTGAGCCTCACCCGAGCAGTGGCGGGCGGGGATGAACAGGTGGCAATGAAGTGTGCCATCTGGCTGGCA
GAGCAACGGGTGCCCCTGAGTGTGCAACTGAAGCCTGAGGTCTCCCCAACGCAGGACATCAGGCTGTGGGTGAGCGTGGAGGATGCTCAG
ATGCACACCGTCACCATCTGGCTCACAGTGCGCCCTGATATGACAGTGGCGTCTCTCAAGGACATGGTTTTTCTGGACTATGGCTTCCCA
CCAGTCTTGCAGCAGTGGGTGATTGGGCAGCGGCTGGCACGAGACCAGGAGACCCTGCACTCCCATGGGGTGCGGCAGAATGGGGACAGT
GCCTACCTCTATCTGCTGTCAGCCCGCAACACCTCCCTCAACCCTCAGGAGCTGCAGCGGGAGCGGCAGCTGCGGATGCTGGAAGATCTG
GGCTTCAAGGACCTCACGCTGCAGCCGCGGGGCCCTCTGGAGCCAGGCCCCCCAAAGCCCGGGGTCCCCCAGGAACCCGGACGGGGGCAG
CCAGATGCAGTGCCTGAGCCCCCACCGGTGGGCTGGCAGTGCCCCGGGTGCACCTTCATCAACAAGCCCACGCGGCCTGGCTGTGAGATG
TGCTGCCGGGCGCGCCCCGAGGCCTACCAGGTCCCCGCCTCATACCAGCCCGACGAGGAGGAGCGAGCGCGCCTGGCGGGCGAGGAGGAG
GCGCTGCGTCAGTACCAGCAGGAGGAAATGGCACTTCAGCTCATTAACTGCCCCGACTACAAGCTCCGGCCATACCAGCACTCCTACCTA
CGCAGCACCGTCATCCTCGTCCTGACCCTGCTCATGATCTGCCTCATGATCGGCATGGCCCACGTCCTGGTGGTCTACCGCGTCCTGGCC
TCCGCGCTCTTCAGCAGCTCGGCCGTGCCCTTCCTGGAGGAGCAGGTGACCACGGCCGTGGTGGTGACCGGGGCTCTGGTGCACTATGTG
ACCATCATCATCATGACCAAGATCAACAGGTGCGTGGCCCTGAAGCTTTGTGACTTCGAGATGCCCAGGACCTTCTCGGAGCGAGAGAGC
AGGTTCACCATCCGCTTCTTCACACTGCAGTTCTTCACCCATTTCTCGTCTCTCATCTACATCGCCTTCATCCTGGGCAGGATCAACGGC
CACCCCGGGAAGTCCACGCGCCTGGCGGGCTTGTGGAAGCTGGAAGAGTGCCACGCCAGCGGCTGCATGATGGACCTCTTCGTGCAGATG
GCCATCATCATGGGCCTGAAGCAGACGCTCAGCAACTGCGTCGAGTACCTGGTCCCGTGGGTGACCCACAAGTGCCGCTCTCTGCGGGCC
TCCGAGTCCGGGCACCTGCCCCGGGACCCCGAGCTCAGGGACTGGCGGCGCAACTACCTTCTGAACCCGGTCAACACCTTCAGCCTGTTC
GACGAGTTCATGGAGATGATGATCCAGTACGGCTTCACCACCATCTTCGTGGCCGCCTTCCCGCTGGCGCCGCTGCTCGCGCTCTTCAGC
AACCTCGTGGAGATCCGCCTGGACGCCATCAAGATGGTCTGGTTGCAGCGGCGCCTGGTGCCGCGCAAGGCCAAGGACATCGGGACCTGG
CTGCAGGTGCTGGAGACCATCGGTGTGCTGGCGGTCATTGCCAATGGGATGGTCATTGCCTTCACATCTGAGTTCATCCCCCGAGTGGTC
TACAAGTACCGCTATAGCCCATGCCTGAAAGAAGGCAACTCTACTGTCGACTGCCTCAAGGGCTACGTCAACCACAGCCTGTCCGTCTTC
CACACCAAGGACTTCCAGGACCCTGATGGGATTGAGGGCTCAGAAAACGTGACTCTGTGCAGATACAGGGACTACCGCAATCCCCCCGAT
TACAACTTCTCCGAGCAGTTCTGGTTCCTCCTGGCCATCCGCCTGGCCTTCGTCATCCTCTTTGAGCACGTGGCCTTGTGCATCAAGCTC
ATCGCCGCCTGGTTCGTGCCCGACATCCCTCAGTCGGTGAAGAACAAGGTTCTGGAGGTGAAGTACCAGAGGCTGCGTGAGAAGATGTGG
CATGGAAGGCAGAGGCTGGGTGGGGTGGGGGCAGGCTCTCGGCCCCCAATGCCTGCCCATCCCACCCCAGCATCCATCTTCAGTGCCAGG
AGCACAGACGTGTAGGGCCAGAGCCCGTCCAGAGGCCACCAGGAGCTGAGACAGTGCCACCACCAGCACCTCCCACAAGCCCACCGCTGT

>72622_72622_2_RBCK1-ANO9_RBCK1_chr20_400375_ENST00000356286_ANO9_chr11_428826_ENST00000332826_length(amino acids)=772AA_BP=294
MGRAGGHTAWLSCSWSPASPRRPGGSISQEARSPPGGWAQPRQMDEKTKKAEEMALSLTRAVAGGDEQVAMKCAIWLAEQRVPLSVQLKP
EVSPTQDIRLWVSVEDAQMHTVTIWLTVRPDMTVASLKDMVFLDYGFPPVLQQWVIGQRLARDQETLHSHGVRQNGDSAYLYLLSARNTS
LNPQELQRERQLRMLEDLGFKDLTLQPRGPLEPGPPKPGVPQEPGRGQPDAVPEPPPVGWQCPGCTFINKPTRPGCEMCCRARPEAYQVP
ASYQPDEEERARLAGEEEALRQYQQEEMALQLINCPDYKLRPYQHSYLRSTVILVLTLLMICLMIGMAHVLVVYRVLASALFSSSAVPFL
EEQVTTAVVVTGALVHYVTIIIMTKINRCVALKLCDFEMPRTFSERESRFTIRFFTLQFFTHFSSLIYIAFILGRINGHPGKSTRLAGLW
KLEECHASGCMMDLFVQMAIIMGLKQTLSNCVEYLVPWVTHKCRSLRASESGHLPRDPELRDWRRNYLLNPVNTFSLFDEFMEMMIQYGF
TTIFVAAFPLAPLLALFSNLVEIRLDAIKMVWLQRRLVPRKAKDIGTWLQVLETIGVLAVIANGMVIAFTSEFIPRVVYKYRYSPCLKEG
NSTVDCLKGYVNHSLSVFHTKDFQDPDGIEGSENVTLCRYRDYRNPPDYNFSEQFWFLLAIRLAFVILFEHVALCIKLIAAWFVPDIPQS

--------------------------------------------------------------

Top

Fusion Gene PPI Analysis for RBCK1-ANO9


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+6121_220252.0511.0IRF3
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+51169_131210.0469.0RNF31
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+61269_131252.0511.0RNF31


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+5111_220210.0469.0IRF3
HgeneRBCK1chr20:400375chr11:428826ENST00000353660+5111_270210.0469.0TAB2
HgeneRBCK1chr20:400375chr11:428826ENST00000356286+6121_270252.0511.0TAB2


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for RBCK1-ANO9


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for RBCK1-ANO9


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource